Arata Corporation · TSE:2733
Arata — Q1 FY03/2024 Earnings Presentation
13 slides from Arata's earnings presentation, August 2023
Slide 1: ARATA Corporation Q1 FY03/2024 Financial Results
NOTICE The slides in this presentation has been translated using a mechanical automatic translation service. In some cases, the translation may be inaccurate or unintended. Please use this service with the understanding that translations are not always accurate. ARATA Corporation Q1 of Fiscal Year E
Slide 2: Q1 of FY03/2024 Highlights
Q1 of FY03/2024 results ■ Q1 of FY03/2024 Highlights Market Environment Due to the rise in Due to the transition of Due to an increase in crude oil prices COVID-19 to Class 5 foreign visitors to Japan Increased consumer Soaring utility costs awareness of Increased flow Growing Raw material cost savi
Slide 3: Consolidated Statements of Income
Q1 of FY03/2024 results ■ Consolidated Statements of Income Q1 of Q1 of Progress YoY change FY03/2023 FY03/2024 Planning rate (Millions of JPY) Results Results Change Rate (%) Rate (%) Net sales 220,051 235,239 15,188 106.9 916,000 25.7 Gross profit 21,534 23,221 1,687 107.8 - - SG&A expenses 18,104
Slide 4: Record high net sales factors
Q1 of FY03/2024 results ■ Q1 of FY03/2024 factors Record high net sales Net Sales: JPY235.239 billion YoY: +JPY15.188 billion 106.9% Q1 of FY03/2023 Cumulative Q1 of FY03/2024 Cumulative Net sales YoY 102.9% Net sales YoY 106.9% ・Increase sales of Monopoly and preferred distribution products ・ Respo
Slide 5: Record high recurring profit factors
Q1 of FY03/2024 results ■ Q1 of FY03/2024 factors Record high recurring profit Ordinary income: JPY4.669 billion YoY: +JPY901 million 123.9% Gross profit: JPY23.221 billion YoY: +JPY1.687 billion 107.8% Gross margin: 9.87% YoY +0.08 points +Factor : Strong sales of exclusive products such as cosmeti
Slide 6: Sales by Category (YoY)
Q1 of FY03/2024 results ■ Sales by Category (YoY) (Millions of JPY) 80,000 71,216 Health & Beauty 67,928 Percentage of Net Sales Q1 of FY03/2023 30.3% Q1 of FY03/2024 60,000 107.0% 112.2% 104.8% 48,055 105.9% 44,189 42,823 41,296 40,000 32,946 31,107 104.4% 23,719 22,725 106.7% 20,000 15,112 14,168
Slide 7: Sales by Business Category (YoY)
Q1 of FY03/2024 results ■ Sales by Business Category (YoY) (Millions of JPY) 140,000 122,801 Drugstores Q1 of FY03/2023 120,000 112,232 Percentage of Net Sales Q1 of FY03/2024 100,000 52.2% 109.4% 80,000 60,000 104.4% 34,041 103.9% 106.8% 40,000 32,598 26,228 104.2% 24,944 25,234 17,146 99.0% 23,355
Slide 8: Consolidated Balance Sheets
Q1 of FY03/2024 results ■ Consolidated Balance Sheets FY03/2023 Q1 of FY03/2024 (Millions of JPY) (Millions of JPY) Current assets Current Current assets Current liabilities liabilities 217,681 158,760 220,606 160,384 74.8% 54.6% 75.1% 54.6% Long-term 30,030 Long-term 28,912 liabilities liabilities
Slide 9: Forecasts for FY03/2024
Q1 of FY03/2024 results ■ Forecasts for FY03/2024 Q1 of FY03/2024 Q2 of FY03/2024 Year-end Progress(%) Progress(%) (Millions of JPY) Results forecast forecast Net sales 235,239 460,000 51.1 916,000 25.7 Operating income 4,347 6,800 63.9 13,700 31.7 Ordinary income 4,669 7,100 65.8 14,300 32.7 Profit
Slide 10: Topics
Q1 of FY03/2024 results Topics 10
Slide 11: Medium-Term Management Plan 2026 Strategy
Q1 of FY03/2024 results ■ Medium-Term Management Plan 2026 Strategy Enhancig our uniqueness by expanding monopoly and preferred distribution products June 2023 New cosmetic brands utilizing the Aarata Group's manufacturing capabilities 『3650 (san roku go zero)』 launched Official brand site Official
Slide 12: Efforts for sustainability
Q1 of FY03/2024 results ■ Efforts for sustainability Award for Excellence Efforts to improve shipping efficiency and truck rotation by elimination of inspection by using ASN data, and sorting and delivery by floor ARATA Group company Japell Co., Ltd. is awarded the Excellence Award at the Supply cha
Slide 13: Cautionary Statement and IR inquiry address
Cautionary Statement with Respect to Forward-Looking Statements This material is solely for information purposes and should not be construed as a solicitation. This document (including the performance plan) has been prepared by us based on reliable information currently available, but it involves